Carlo Lazzaro

18PUBLICATIONS
21CO-AUTHORS
Models of care and place of birthCoding, information theory and compressionMacroeconomics (incl. monetary and fiscal theory)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Optical technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 12, 2026
Managing severe gestational hypertension in Italy: a cost description.

|Mar 21, 2025
COVID-19-related hospitalizations in Italy: an application of the synthetic control method to investigate the trajectory of diagnosis-related group 79 and its counterfactual during 2010-2021.

Carlo Lazzaro, Giovanni Fattore, Angelo Guido Corsico

|Jan 21, 2025
Matters arising: cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing-remitting multiple sclerosis: a systematic review.

Carlo Lazzaro, Roberto Bergamaschi, Mauro Zaffaroni

|Oct 05, 2023
Inebilizumab for neuromyelitis optica spectrum disorders in Italy: a budget impact model.

Carlo Lazzaro, Nicola Amedeo Mazzanti, Silvia Rossi

|Dec 28, 2022
A latanoprost cationic emulsion (STN1013001) vs. other latanoprost formulations (Latanoprost) in open angle glaucoma/ocular hypertension and ocular surface disease: an Italian cost-utility analysis.

Carlo Lazzaro, Cécile van Steen, Giorgio Ghirelli

|May 09, 2022
Cost-Utility Analysis of STN1013001, a Latanoprost Cationic Emulsion, versus Other Latanoprost Formulations (Latanoprost) in Open-Angle Glaucoma or Ocular Hypertension and Ocular Surface Disease in France.

Carlo Lazzaro, Cécile van Steen, Florent Aptel

Pageof 3

Frequent Collaborators

2 joint publications

Cécile van Steen

2 joint publications

Luigi Angelillo

2 joint publications

Roberto Bergamaschi

2 joint publications

Mauro Zaffaroni